Double count theory for US myocardial infarction rate
This article was originally published in Clinica
The heart attack rate in the US may be greatly overstated, according to a study published in the May issue of Medical Care. Hospitals may be double counting a significant percentage of patients suffering an acute myocardial infarction, Colorado researchers reported after analysing hospital discharge data from eight states. The double count rate ranged from 10% to 15% in the eight states, said John M Westfall and Joe McGloin. Older patients and females were less likely to be double counted.
You may also be interested in...
Liquid biopsy start-up Grail Inc. announced that a study of almost 6,700 participants found that its blood test could detect more than 50 types of cancer with a low false-positive rate. See what Minetta Liu, study co-lead author and a Mayo Clinic professor of oncology, had to say about the research.
Sanofi’s next-generation meningococcal vaccine, broader use of Bristol-Myers Squibb’s Reblozyl move toward approval; United Therapeutics foreshadows Trevyent regulatory difficulties.
Biopharma is working on a reputation renaissance as the public looks to industry for treatments and vaccines for the COVID-19 epidemic and drug pricing concerns take a back seat.